Angels Partners logo
  • Platform
    Investor DatabaseOutreach AutomationAI Fundraising CRMDone-For-You Fundraising
  • Find Investors
    By TypeAngel InvestorsVenture Capital Firms
    By LocationUnited StatesUnited KingdomCanadaAustraliaGermanyFranceNetherlandsSingaporeSwedenSpainItalySwitzerlandAll countries ›
    By SectorSaaSFintechAI & Machine LearningHealthTechCleanTechBiotechEdTechPropTechDeepTech
  • Funding
    Startup GrantsUK GrantsUS GrantsVenture DebtRevenue-Based FinancingNon-Dilutive Funding Guide
  • Resources
    Fundraising RoadmapPitch Deck TemplateFinancial ModelingBlogAbout Us
  • Compare
    vs OpenVCvs Fundablevs FounderSuiteSee all comparisons ›
  • Pricing
  • Sign Up Free
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm Lightstone Ventures
websitelinkedintwittergoogle

Lightstone Ventures

map marker logo Boston Massachusetts |  U.S.A.

Investor TypeFirm
Type of FundVC
IndustriesBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Oncology • Pharmaceutical (& Medicine)
StagesEarly, Seed, Series A, Series B
InvestingUnited States • Canada • Israel • Belgium • Ireland
Investment Range $100,000  -  $5,000,000
Investment Sweet Spot $1,500,000
Assets Under Management $250,000,000

Who are the key investors at Lightstone Ventures?

Who co-invests with Lightstone Ventures?

What is Lightstone Ventures?

Lightstone Ventures is a venture capital firm specializing in early-stage investments within the healthcare and life sciences sectors. Founded in 2012 and headquartered in Menlo Park, California, the firm targets emergent companies primarily in the biotech, medical devices, therapeutics, and novel bio-pharmaceutical industries.

With a committed capital fund of $250 million, they deploy investments ranging from $100,000 to $5,000,000, focusing on early, seed, and Series A through B funding rounds. The firm prides itself on a 'thesis-driven' investment approach, emphasizing the identification and support of disruptive technologies anticipated to transform patient outcomes across focused market sectors. Lightstone Ventures' philosophy extends beyond mere financial backing; they engage actively with portfolio companies, contributing nearly 100 years of collective operational expertise, strategically guiding founders from inception through commercialization.

Their investment team has been instrumental in notable life science exits, reflected in a track record that spans initial public offerings and acquisitions, showcasing success stories in biotech and medtech. In the biotech domain, Lightstone Ventures concentrates on innovative drug development in multiple disease areas, including CNS disorders, immunology, oncology, and ophthalmology.

Regarding medtech, they are intrigued by the convergence of technology, medicine, and consumer health, focusing on personal medicines, therapeutics, and analytics platforms revolutionizing medical technology across various diseases.

The firm maintains a global presence, capitalizing on an international footprint to leverage strategic and financial funding sources outside the U.S., as well as unique development and commercialization strategies. Collaboration with founders is key to their ethos; they seek visionary entrepreneurs dedicated to creating industry-first or leading products, and they help assemble adept management teams to materialize those visions. Demonstrating the breadth of their portfolio diversity, Lightstone Ventures features numerous companies spanning biopharmaceuticals, active exits & IPOs, medtech, and therapeutics, each advancing medical science and patient care.

Lightstone Ventures's investments on record

EarLens $87,000,000.00 Later stage VC
Willow (Electronics) $42,700,000.00 Later stage VC
Cyteir Therapeutics $40,200,000.00 Later stage VC
Ligature Therapeutics $6,000,000.00 Early stage VC
Amber Therapeutics $100,000,000.00 Series A
ProVerum Medical $34,000,000.00 Series A
Catamaran Bio $42,000,000.00 Series A
Tagworks Pharmaceuticals $65,000,000.00 Series A
Nuvaira $79,000,000.00 Series E
Tweets by Lightstone Ventures

What are the investment firms similar to Lightstone Ventures

Similar Investor Longwood Fund
Longwood Fund
Similar Investor Parthenon Capital Partners
Parthenon Capital Partners
Similar Investor Alpine Venture Partners
Alpine Venture Partners
Similar Investor Adage Capital Management
Adage Capital Management
Similar Investor RA Capital Management
RA Capital Management
Similar Investor SV Health Investors
SV Health Investors
Similar Investor Acceleration International
Acceleration International
Similar Investor T1D Fund
T1D Fund
Similar Investor Arctaris Capital Partners
Arctaris Capital Partners
Similar Investor Bluescape Resources
Bluescape Resources

How to connect with investors at Lightstone Ventures?

Discover introductions paths, using your LinkedIn network, work your way to investors you can get connected to


Generate Warm Introductions >
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 71-75 Shelton Street, Covent Garden, WC2H 9JQ
  • London, U.K.
  •   contact@angelspartners.com
  • Fundraising Guide
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Contact Us
Copyright © 2026 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo